GENE ONLINE|News &
Opinion
Blog

2026-01-23|

Magnetostatic Pumping Tested in Ex Vivo ECMO Model by Zolala et al. for Potential to Reduce Blood Damage

by GOAI
Share To

Researchers have introduced a new technique called magnetostatic pumping, which has been tested in an ex vivo extracorporeal membrane oxygenation (ECMO) model. The study, led by Zolala et al. and published in 2026, explores the potential of this method to improve ECMO efficiency. Magnetostatic pumping involves the use of magnetic fields to drive fluid flow, offering an alternative to traditional mechanical pumps commonly used in ECMO systems.

The research team conducted experiments using this approach within a controlled ex vivo environment to evaluate its performance. Their findings suggest that magnetostatic pumping may enhance the delivery of mechanical circulatory support by reducing complications associated with conventional ECMO methods, such as blood damage or clot formation caused by mechanical components. While further investigation is necessary to confirm these results and assess clinical applications, the study highlights a promising avenue for advancing ECMO technology.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 24, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
ICE Launches FTSE South Korea RIC Capped Index Futures on February 9, 2026
2026-02-08
New Model Maps Pedestrian Foot Traffic Across New York City During Peak Travel Periods
2026-02-08
TG Therapeutics Partners with Christina Applegate to Raise Awareness About Multiple Sclerosis
2026-02-08
New Program Resilient Together for Dementia Addresses Mental Health Needs of Patients and Caregivers
2026-02-08
Swiss Researchers Assess Feasibility of B2C Digital Diabetes Screening Model
2026-02-08
Banyan Gold Extends Mineralization at Airstrip Deposit in Yukon to 350 Meters
2026-02-08
Point-of-Care Testing Found as Accurate as Laboratory Testing for Hepatitis B DNA
2026-02-08
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top